SwedenBIO Björn Kull has doctorate degree in Neuropharmacology from Karolinska Institutet and joined Sweden Bio in January 2012. He brings more than 15 years of experience in management and research strategy and knowledge of the various national and European funding programs both from an academic and an industry perspective. His previous position was VP discovery Biology at Actar AB.
Invest Sweden Peter Bramberg is head of the life science business unit at Invest Sweden, Cleantech, Invest Sweden. Sweden is a great place to access cutting-edge research in the medical field. It is the source of a number of groundbreaking innovations and home to two of Europe’s most distinguished biotech clusters. Many companies capitalize on Sweden for in-licensing, clinical research or partnerships with...
